tm
Seeing Is Believing
tm
Seeing Is Believing
Neurobo Pharmaceuticals's activity chart (see below) currently has 5 price targets and 5 ratings on display.
Analysts average stock forecasts to be materialized ratio is 63.75% with an average time for these price targets to be met of 104.75 days.
Most recent stock forecast was given by from LADENBURG on 13-Dec-2022. First documented stock forecast 30-Aug-2016.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 13-Dec-2022
$6
$4.11 (217.46%)
$6
3 years 8 months 29 days ago
(13-Dec-2022)
2/2 (100%)
$-7.2 (-54.55%)
18
Buy Since 15-Jun-2020
$4800
5 years 7 months 10 days ago
(01-Feb-2021)
0/1 (0%)
$2520 (110.53%)
Hold Since 13-Aug-2018
$12000
$11998.11 (634820.62%)
$108000
8 years 29 days ago
(13-Aug-2018)
3/5 (60%)
$2040 (20.48%)
130
Hold Since 10-Aug-2018
$12000
$11998.11 (634820.62%)
8 years 1 months 1 days ago
(10-Aug-2018)
1/1 (100%)
$1200 (11.11%)
27
$12000
$11998.11 (634820.62%)
8 years 1 months 2 days ago
(09-Aug-2018)
1/2 (50%)
$-7620 (-38.84%)
1
What is NRBO (Neurobo Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on NRBO (Neurobo Pharmaceuticals)?
Which analyst has the most public recommendations on NRBO (Neurobo Pharmaceuticals)?
Which analyst is the currently most bullish on NRBO (Neurobo Pharmaceuticals)?
Which analyst is the currently most reserved on NRBO (Neurobo Pharmaceuticals)?
